⌘K

Login Start Free

Home/Filings/4/0001209191-21-038179

4//SEC Filing

Currie Mark G 4

Accession 0001209191-21-038179

CIK 0001446847other

View on SEC.gov Company Profile

Filed

Jun 3, 8:00 PM ET

Accepted

Jun 4, 4:01 PM ET

Size

4.8 KB

Accession

0001209191-21-038179

Insider Transaction Report

Form 4

Period: 2021-06-02

IRONWOOD PHARMACEUTICALS INCIRWD

Chief Scientific Officer

Transactions

Award
Class A Common Stock
2021-06-02+22,766→ 593,758 total

Footnotes (1)

[F1]The restricted stock, granted pursuant to the Director Compensation Policy effective May 2019, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

IRONWOOD PHARMACEUTICALS INC

CIK 0001446847

Entity typeother

Related Parties

1

filerCIK 0001478244

Filing Metadata

Form type: 4
Filed: Jun 3, 8:00 PM ET
Accepted: Jun 4, 4:01 PM ET
Size: 4.8 KB

View on SEC.gov